| Scientific Name |
Riociguat
|
|---|---|
| Brand Name |
Adempas
|
| Risk |
New contraindication regarding treatment of patients with pulmonary hypertension associated with idiopathic interstitial pneumonias (PH-IIP).
|
| Dear Healthcare Professional Communication (DHPC) for Healthcare Professionals |
|